Single-dose therapeutic interfering particle lowers SARS-CoV-2 pathogenesis and shedding among hamsters

Por um escritor misterioso

Last updated 07 junho 2024

Single-dose therapeutic interfering particle lowers SARS-CoV-2 pathogenesis and shedding among hamsters

Researchers reported that a single-dose therapeutic interfering particle (TIP) lowers SARS-CoV-2 pathogenesis and shedding among hamsters.

SARS-CoV-2 and COVID-19 Pathogenesis: A Review

Drug-based therapeutic strategies for COVID-19-infected patients and their challenges

SARS-CoV-2 Antiviral Therapy Clinical Microbiology Reviews

Cureus, From Emergence to Endemicity: A Comprehensive Review of COVID-19

COVID-19: systemic pathology and its implications for therapy

Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment, Microbial Cell Factories

Single-dose therapeutic interfering particle lowers SARS-CoV-2 pathogenesis and shedding among hamsters

SARS-CoV-2: The Virus, Its Biology and COVID-19 Disease-Counteracting Possibilities

Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis

Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster models - eBioMedicine

COVID-19 convalescent plasma and randomized clinical trials: explaining conflicting outcomes and finding signals of efficacy

Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities

Organoids to Remodel SARS-CoV-2 Research: Updates, Limitations and Perspectives

Recomendado para você